We are live on !
Find out more
Daventry Group Portfolio holdings
AUM
$133M
Turnover
53.85%
1-Year Est. Return
32.28%
This Fund
S&P 500
This Quarter Est. Return
+15.79%
1 Year Est. Return
+32.28%
3 Year Est. Return
+26.25%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$143M
AUM Growth
+$27.1M
(+23%)
Cap. Flow
+$11M
Cap. Flow % of AUM
Cap. Flow %
7.68%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
6
Reduced
–
Closed
1
Avg Time Held
1
year
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$14.3M |
| 2 |
Elastic
ESTC
|
+$3.89M |
| 3 |
Everbridge, Inc. Common Stock
EVBG
|
+$3.44M |
| 4 |
Health Catalyst
HCAT
|
+$2.52M |
| 5 |
NEWR
New Relic, Inc.
NEWR
|
+$1.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OSH
Oak Street Health, Inc.
OSH
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 77.72% |
| 2 | Healthcare | 22.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Tenable Holdings
TENB
$4.4B
| $29.1M | 20.36% |
612,433
+38,979
| +7% | +$1.66M |
2021 Q4
5 quarters
|
|
|
NEWR
2
DELISTED
New Relic, Inc.
NEWR
| $21.5M | 15.05% |
285,646
+28,919
| +11% | +$1.95M |
2022 Q2
3 quarters
|
|
|
3
Elastic
ESTC
$9.04B
| $21.2M | 14.81% |
365,725
+68,188
| +23% | +$3.89M |
2021 Q4
5 quarters
|
|
4
PTC
PTC
$21.2B
| $19.9M | 13.95% |
155,552
+9,875
| +7% | +$1.26M |
2021 Q4
5 quarters
|
|
|
5
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $19.4M | 13.55% |
558,678
+107,530
| +24% | +$3.44M |
2022 Q1
4 quarters
|
|
|
6
Health Catalyst
HCAT
$111M
| $19.1M | 13.37% |
1,637,111
+197,497
| +14% | +$2.52M |
2021 Q4
5 quarters
|
|
|
7
Charles River Laboratories
CRL
$16.2B
| $12.7M | 8.91% |
+63,123
| New | +$14.3M |
2023 Q1
0 quarters
|
|
|
OSH
8
DELISTED
Oak Street Health, Inc.
OSH
| – | – |
-838,577
| Closed | -$18M | – |
|
Similar funds
HPM
Daventry Group's Q1 2023 Portfolio in Review
As of Q1 2023, Daventry Group held 8 positions worth $143M, up 23% from $116M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Daventry Group deployed $11M of net new capital in Q1 2023, opening 1 new position and adding to 6 existing holdings. Its largest new stake was Charles River Laboratories: 63,123 shares worth $12.7M.
By sector, the portfolio is most concentrated in Technology at 78% of assets, up from 71% a quarter earlier, followed by Healthcare.
On the sell side, the most notable exit was Oak Street Health, Inc., an estimated $18M sold.
- Daventry Group's largest Q1 2023 buy was Charles River Laboratories: 63,123 shares worth $12.7M.
- Daventry Group added most to Elastic in Q1 2023, an estimated $3.89M increase.
- Daventry Group fully exited Oak Street Health, Inc. in Q1 2023, selling an estimated $18M.
- Daventry Group's ten largest holdings make up 100% of its $143M portfolio in Q1 2023.
- Daventry Group opened 1 new position and closed 1 in Q1 2023.
- Daventry Group's portfolio value rose 23% quarter-over-quarter to $143M.
Based on Daventry Group's 13F filing for Q1 2023, filed 12 May 2023.